Literature DB >> 16844105

Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.

Ysabel López Ramírez1, Merlín Vivenes, Aixa Miller, Aníbal Pulido, José López Mora, Carmen Luisa Arocha-Piñango, Rita Marchi.   

Abstract

BACKGROUND: Recurrent miscarriage (RM) syndrome is not an uncommon obstetrical problem of multifactorial etiology. We investigated the role of the coagulation factor XIII (FXIII) Val34Leu polymorphism in RM.
METHODS: We recruited 80 subjects (40 normal and 40 with history of RM; of each group 20 pregnant and 20 non-pregnant) and analyzed the prevalence of this polymorphism. The women recruited for the present study had similar age and did not have history of any hemostatic disorders. FXIII levels and activity and the rate of fibrin cross-linking by FXIII genotype Val34Val and Val34Leu were studied.
RESULTS: Genotype analyses of patients and normal revealed that the frequencies distribution of Val/Val and Val/leu were statistically similar (P<0.05): 62.5% and 60%, and 37.5% and 40%, respectively; no Leu/leu genotype was found. The FXIII-A subunit levels and activity were also found similar between Val/Val and Val/leu genotypes in the different groups, pregnant and non-pregnant, normal or with RM. The rate of FXIII alpha and gamma-chains fibrin cross-linking was not different between the 2 genotypes.
CONCLUSION: From our results we conclude that FXIII Val34Leu polymorphism does not appear to be associated to RM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844105     DOI: 10.1016/j.cca.2006.05.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis.

Authors:  Jie Li; Hongbo Wu; Yang Chen; Huimei Wu; Hong Xu; Liuming Li
Journal:  J Assist Reprod Genet       Date:  2015-04-11       Impact factor: 3.412

2.  Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.

Authors:  Astrid Dossenbach-Glaninger; Mick van Trotsenburg; Christian Oberkanins; Johanna Atamaniuk
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

3.  Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism.

Authors:  Maria Diaz-Nuñez; Aintzane Rabanal; Antonia Expósito; Marcos Ferrando; Fernando Quintana; Jose Manuel Soria; Roberto Matorras
Journal:  J Reprod Infertil       Date:  2019 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.